Literature DB >> 15007702

Idiopathic intracranial hypertrophic pachymeningitis: two case reports and review of the literature.

Giancarlo D'Andrea1, Giuseppe Trillò, Paolo Celli, Raffaelino Roperto, Francesco Crispo, Luigi Ferrante.   

Abstract

In 1949, Naffziger et al. first described idiopathic intracranial hypertrophic pachymeningitis (IIHP) as an aseptic, diffuse inflammatory disease that causes thickening of the dura mater and often headache and progressive multiple nerve palsies due to fibrous entrapment or ischemic damage of neurovascular structures. Pachymeningeal thickening can be diffuse or nodular. We report two cases of IIHP; one was affected by diffuse IIHP, while the other presented focal IIHP mimicking a convexity meningioma. We examine the differential diagnosis between IIHP and other known causes of hypertrophic pachymeningitis. We also discuss the clinical bases of treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15007702     DOI: 10.1007/s10143-004-0321-1

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  41 in total

1.  Candida pachymeningitis with multiple cranial nerve pareses.

Authors:  J M Gorell; W A Palutke; J L Chason
Journal:  Arch Neurol       Date:  1979-11

2.  Chronic pachymeningitis; report of a case and review of the literature.

Authors:  H C NAFFZIGER; W E STERN
Journal:  Arch Neurol Psychiatry       Date:  1949-10

3.  Optic neuropathy associated with hypertrophic cranial pachymeningitis.

Authors:  T Harada; T Ohashi; K Ohki; H Kato; M Takamura; K Yoshida; H Matsuda; Y Sawamura; T Itoh
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

4.  Idiopathic hypertrophic cranial pachymeningitis with accumulation of thallium-201 on single-photon emission CT.

Authors:  H Nishioka; H Ito; J Haraoka; Y Yamada; H Nojima
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

5.  Visual loss from idiopathic intracranial pachymeningitis.

Authors:  B L Lam; D A Barrett; J S Glaser; N J Schatz; H H Brown
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

Review 6.  Idiopathic hypertrophic cranial pachymeningitis. Report of three cases.

Authors:  A N Mamelak; W M Kelly; R L Davis; M L Rosenblum
Journal:  J Neurosurg       Date:  1993-08       Impact factor: 5.115

7.  Hypertrophic cranial pachymeningitis due to Aspergillus flavus.

Authors:  H Murai; J Kira; T Kobayashi; I Goto; H Inoue; K Hasuo
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

8.  Idiopathic hypertrophic cranial pachymeningitis: a case report.

Authors:  F Kioumehr; S A Rooholamini; I Yaghmai; R Verma
Journal:  Neuroradiology       Date:  1994-05       Impact factor: 2.804

9.  Idiopathic hypertrophic cranial pachymeningitis associated with hydrocephalus and myocarditis: remarkable steriod-induced remission of hypertrophic dura mater.

Authors:  M Tanaka; M Suda; Y Ishikawa; J Fujitake; H Fujii; Y Tatsuoka
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

10.  [Multiple cranial nerve involvement associated with tentorial pachymeningitis of granulomatous type].

Authors:  S Ghilain; V Delreux; L Kevers; C J Sindic; P Mathurin; E C Laterre
Journal:  Acta Neurol Belg       Date:  1988 Mar-Apr       Impact factor: 2.396

View more
  7 in total

Review 1.  Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.

Authors:  Armando De Virgilio; Marco de Vincentiis; Maurizio Inghilleri; Giovanni Fabrini; Michela Conte; Andrea Gallo; Maria Ida Rizzo; Antonio Greco
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Idiopathic pachymeningitis presenting with progressive sensorineural hearing loss, tinnitus and confusion.

Authors:  Aron Pollack; Brandon E Cohen; Mari Hagiwara; Pamela C Roehm
Journal:  Otol Neurotol       Date:  2013-08       Impact factor: 2.311

3.  Toxoplasmic pachymeningitis with visual field impairment in a single-eyed patient and a literature review.

Authors:  Nicolas Bonnin; Frédéric Chiambaretta; Miguel Ulla; Frédéric Taithe; Emmanuel Chabert; Béatrice Claise; Franck Bacin
Journal:  Oman J Ophthalmol       Date:  2012-01

4.  IgG4-related intracranial hypertrophic pachymeningitis with skull hyperostosis: a case report.

Authors:  Che-Kuang Lin; Dar-Ming Lai
Journal:  BMC Surg       Date:  2013-09-21       Impact factor: 2.102

Review 5.  Leptomeningeal form of Immunoglobulin G4-related hypertrophic meningitis with perivascular spread: a case report and review of the literature.

Authors:  Jasmina Boban; Selin Ardalı; Majda M Thurnher
Journal:  Neuroradiology       Date:  2018-05-07       Impact factor: 2.804

6.  A rare case report on hypertrophic pachymeningitis: Serum IgG4-related disease.

Authors:  Sushil Rayamajhi; Ramesh Shrestha; Neela Sunuwar; Rekha Shrestha; Sunita Shrestha; Jasmine Bartaula; Ghanashyam Kharel
Journal:  Radiol Case Rep       Date:  2022-09-17

Review 7.  Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.

Authors:  T Bosman; C Simonin; D Launay; S Caron; A Destée; L Defebvre
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.